{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:53:07Z","timestamp":1779346387450,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1508220"],"award-info":[{"award-number":["U1508220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jpba.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T11:39:53Z","timestamp":1554723593000},"page":"180-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A systemic combined nontargeted and targeted LC-MS based metabolomic strategy of plasma and liver on pathology exploration of alpha-naphthylisothiocyanate induced cholestatic liver injury in mice"],"prefix":"10.1016","volume":"171","author":[{"given":"Song","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-nong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-shun","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.jpba.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jpba.2019.04.009_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2017.09.051","article-title":"Early indications of ANIT-induced cholestatic liver injury: alteration of hepatocyte polarization and bile acid homeostasis","volume":"110","author":"Yang","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.jpba.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jpba.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2015.12.024","article-title":"Caffeic acid prevents acetaminophen-induced liver injury by activating the Keap1-Nrf2 antioxidative defense system","volume":"91","author":"Pang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jpba.2019.04.009_bib0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpba.2017.06.049","article-title":"An integrative investigation of the toxicity of Aconiti kusnezoffii radix and the attenuation effect of its processed drug using a UHPLC-Q-TOF based rat serum and urine metabolomics strategy","volume":"145","author":"Sui","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.04.009_bib0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fphar.2016.00014","article-title":"Metabolomics coupled with multivariate data and pathway analysis on potential biomarkers in Cholestasis and intervention effect of Paeonia lactiflora pall","volume":"7","author":"Ma","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.jpba.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.fct.2017.02.030","article-title":"Identification of urine tauro-beta-muricholic acid as a promising biomarker in Polygoni Multiflori Radix-induced hepatotoxicity by targeted metabolomics of bile acids","volume":"108","author":"Zhao","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.jpba.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.taap.2007.11.015","article-title":"Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum","volume":"227","author":"Wei","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jpba.2019.04.009_bib0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpba.2018.09.055","article-title":"Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancer","volume":"163","author":"Callejon-Leblic","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2019.04.009_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2017.05.015","article-title":"Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids","volume":"172","author":"Yang","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jpba.2019.04.009_bib0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2018.03.012","article-title":"Integration of (1)H NMR- and UPLC-Q-TOF\/MS-based plasma metabonomics study to identify diffuse axonal injury biomarkers in rat","volume":"140","author":"Zhang","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpba.2019.04.009_bib0060","series-title":"Bioanalytical Method Validation Guidance for Industry","author":"USFDA","year":"2018"},{"issue":"5","key":"10.1016\/j.jpba.2019.04.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90780","article-title":"Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response","volume":"2","author":"Cai","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpba.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mam.2017.04.004","article-title":"The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"56","author":"Chow","year":"2017","journal-title":"Mol. Aspects Med."},{"issue":"7075","key":"10.1016\/j.jpba.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpba.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbalip.2014.05.001","article-title":"Transcription factor networks regulating hepatic fatty acid metabolism","volume":"1851","author":"Karagianni","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2019.04.009_bib0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.fct.2014.05.009","article-title":"Alpha-Linolenic acid: nutraceutical, pharmacological and toxicological evaluation","volume":"70","author":"Kim","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jpba.2019.04.009_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.jpba.2019.04.009_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-017-1311-y","article-title":"Alterations in lipid, amino acid, and energy metabolism distinguish Crohn's disease from ulcerative colitis and control subjects by serum metabolomic profiling","volume":"14","author":"Scoville","year":"2018","journal-title":"Metabolomics"},{"issue":"5","key":"10.1016\/j.jpba.2019.04.009_bib0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbalip.2013.10.014","article-title":"Sphingolipid homeostasis in the web of metabolic routes","volume":"1841","author":"Aguilera-Romero","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.jpba.2019.04.009_bib0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpba.2019.04.009_bib0110","article-title":"Sphingolipid metabolism in non-alcoholic fatty liver diseases","author":"Regnier","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.jpba.2019.04.009_bib0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.aca.2017.12.006","article-title":"Metabolomics study of early metabolic changes in hepatic HepaRG cells in response to rosemary diterpenes exposure","volume":"1037","author":"Acunha","year":"2018","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.jpba.2019.04.009_bib0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.jpba.2019.04.009_bib0125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbrc.2018.05.078","article-title":"Non-alcoholic fatty liver disease: insights from sphingolipidomics","volume":"504","author":"Montefusco","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.jpba.2019.04.009_bib0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.dld.2010.02.008","article-title":"Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats","volume":"42","author":"Glaser","year":"2010","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.jpba.2019.04.009_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbalip.2014.04.008","article-title":"Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice","volume":"1851","author":"Qi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.jpba.2019.04.009_bib0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2982.2012.01893.x","article-title":"Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome","volume":"24","author":"Duboc","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"issue":"10","key":"10.1016\/j.jpba.2019.04.009_bib0145","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.jpba.2019.04.009_bib0150","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518329108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518329108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T01:43:38Z","timestamp":1565142218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518329108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":30,"alternative-id":["S0731708518329108"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.04.009","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systemic combined nontargeted and targeted LC-MS based metabolomic strategy of plasma and liver on pathology exploration of alpha-naphthylisothiocyanate induced cholestatic liver injury in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}